A new donation is fuelling research at the University of Alberta into the use of medical cannabis to treat some incurable diseases.
The $300,000 in funding from Atlas Biotechnologies, an Edmonton-based medical cannabis producer, will back studies into the effectiveness of using weed to treat multiple sclerosis (MS), Alzheimer’s disease and Huntington’s disease.
Many people already use cannabis to cope with these diseases, but researchers hope to find some scientific backing for the anecdotal success stories.
“There isn’t solid scientific evidence for most of what people are saying about cannabis,” said Ross Tsuyuki, who is supervising the research in his role as the chair of the U of A’s department of pharmacology.
– Read the entire article at Edmonton Journal.